nodes	percent_of_prediction	percent_of_DWPC	metapath
Ospemifene—CYP3A4—Fingolimod—multiple sclerosis	0.123	0.152	CbGbCtD
Ospemifene—CYP2C19—Prednisone—multiple sclerosis	0.0992	0.122	CbGbCtD
Ospemifene—CYP2B6—Dexamethasone—multiple sclerosis	0.0975	0.12	CbGbCtD
Ospemifene—CYP3A4—Methylprednisolone—multiple sclerosis	0.0792	0.0977	CbGbCtD
Ospemifene—CYP2C19—Dexamethasone—multiple sclerosis	0.062	0.0765	CbGbCtD
Ospemifene—CYP3A4—Triamcinolone—multiple sclerosis	0.06	0.0741	CbGbCtD
Ospemifene—Haemorrhagic stroke—Fingolimod—multiple sclerosis	0.06	0.412	CcSEcCtD
Ospemifene—CYP3A4—Mitoxantrone—multiple sclerosis	0.0578	0.0713	CbGbCtD
Ospemifene—CYP2C9—Dexamethasone—multiple sclerosis	0.0515	0.0636	CbGbCtD
Ospemifene—CYP3A4—Betamethasone—multiple sclerosis	0.0515	0.0635	CbGbCtD
Ospemifene—CYP3A4—Prednisolone—multiple sclerosis	0.0508	0.0627	CbGbCtD
Ospemifene—CYP3A4—Prednisone—multiple sclerosis	0.048	0.0592	CbGbCtD
Ospemifene—CYP3A4—Dexamethasone—multiple sclerosis	0.03	0.037	CbGbCtD
Ospemifene—Cerebral haemorrhage—Fingolimod—multiple sclerosis	0.0168	0.115	CcSEcCtD
Ospemifene—Neoplasm malignant—Cladribine—multiple sclerosis	0.00616	0.0423	CcSEcCtD
Ospemifene—Neoplasm malignant—Azathioprine—multiple sclerosis	0.00501	0.0344	CcSEcCtD
Ospemifene—Connective tissue disorder—Fingolimod—multiple sclerosis	0.00458	0.0315	CcSEcCtD
Ospemifene—Angiopathy—Fingolimod—multiple sclerosis	0.00423	0.029	CcSEcCtD
Ospemifene—Pranlukast—TNF—multiple sclerosis	0.00389	1	CrCbGaD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00343	0.0236	CcSEcCtD
Ospemifene—Skin disorder—Fingolimod—multiple sclerosis	0.00322	0.0221	CcSEcCtD
Ospemifene—Deep vein thrombosis—Methotrexate—multiple sclerosis	0.00283	0.0195	CcSEcCtD
Ospemifene—Vaginal discharge—Methotrexate—multiple sclerosis	0.00283	0.0195	CcSEcCtD
Ospemifene—Connective tissue disorder—Cladribine—multiple sclerosis	0.0026	0.0178	CcSEcCtD
Ospemifene—Angiopathy—Cladribine—multiple sclerosis	0.0024	0.0165	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00194	0.0134	CcSEcCtD
Ospemifene—Skin disorder—Cladribine—multiple sclerosis	0.00182	0.0125	CcSEcCtD
Ospemifene—Hyperhidrosis—Cladribine—multiple sclerosis	0.00181	0.0125	CcSEcCtD
Ospemifene—Breast disorder—Methylprednisolone—multiple sclerosis	0.00171	0.0117	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00158	0.0109	CcSEcCtD
Ospemifene—Skin disorder—Azathioprine—multiple sclerosis	0.00148	0.0102	CcSEcCtD
Ospemifene—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00128	0.00882	CcSEcCtD
Ospemifene—Skin disorder—Mitoxantrone—multiple sclerosis	0.0012	0.00823	CcSEcCtD
Ospemifene—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00119	0.00819	CcSEcCtD
Ospemifene—Angiopathy—Methylprednisolone—multiple sclerosis	0.00119	0.00815	CcSEcCtD
Ospemifene—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00115	0.0285	CbGpPWpGaD
Ospemifene—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00115	0.0285	CbGpPWpGaD
Ospemifene—Breast disorder—Methotrexate—multiple sclerosis	0.00113	0.00776	CcSEcCtD
Ospemifene—Angiopathy—Dexamethasone—multiple sclerosis	0.00108	0.00741	CcSEcCtD
Ospemifene—Angiopathy—Betamethasone—multiple sclerosis	0.00108	0.00741	CcSEcCtD
Ospemifene—ESR1—ATF-2 transcription factor network—IL23A—multiple sclerosis	0.00103	0.0256	CbGpPWpGaD
Ospemifene—Connective tissue disorder—Prednisone—multiple sclerosis	0.00102	0.00699	CcSEcCtD
Ospemifene—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000978	0.00672	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000962	0.00661	CcSEcCtD
Ospemifene—Angiopathy—Prednisone—multiple sclerosis	0.000939	0.00645	CcSEcCtD
Ospemifene—Skin disorder—Methylprednisolone—multiple sclerosis	0.000902	0.0062	CcSEcCtD
Ospemifene—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.0009	0.00618	CcSEcCtD
Ospemifene—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000898	0.00617	CcSEcCtD
Ospemifene—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000816	0.00561	CcSEcCtD
Ospemifene—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000816	0.00561	CcSEcCtD
Ospemifene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000789	0.0196	CbGpPWpGaD
Ospemifene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000789	0.0196	CbGpPWpGaD
Ospemifene—Angiopathy—Methotrexate—multiple sclerosis	0.000785	0.00539	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000762	0.00523	CcSEcCtD
Ospemifene—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000727	0.0181	CbGpPWpGaD
Ospemifene—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000727	0.0181	CbGpPWpGaD
Ospemifene—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000718	0.0179	CbGpPWpGaD
Ospemifene—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000718	0.0179	CbGpPWpGaD
Ospemifene—Skin disorder—Prednisone—multiple sclerosis	0.000714	0.00491	CcSEcCtD
Ospemifene—Hyperhidrosis—Prednisone—multiple sclerosis	0.000711	0.00488	CcSEcCtD
Ospemifene—ESR1—Nuclear Receptors—PGR—multiple sclerosis	0.000684	0.017	CbGpPWpGaD
Ospemifene—ESR1—Nuclear signaling by ERBB4—PGR—multiple sclerosis	0.00067	0.0167	CbGpPWpGaD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000637	0.00437	CcSEcCtD
Ospemifene—Skin disorder—Methotrexate—multiple sclerosis	0.000597	0.0041	CcSEcCtD
Ospemifene—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000594	0.00408	CcSEcCtD
Ospemifene—ESR1—ATF-2 transcription factor network—SELE—multiple sclerosis	0.00059	0.0147	CbGpPWpGaD
Ospemifene—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000589	0.0147	CbGpPWpGaD
Ospemifene—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000589	0.0147	CbGpPWpGaD
Ospemifene—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000549	0.0137	CbGpPWpGaD
Ospemifene—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000549	0.0137	CbGpPWpGaD
Ospemifene—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000542	0.0135	CbGpPWpGaD
Ospemifene—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000542	0.0135	CbGpPWpGaD
Ospemifene—ESR1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00054	0.0134	CbGpPWpGaD
Ospemifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00052	0.0129	CbGpPWpGaD
Ospemifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00052	0.0129	CbGpPWpGaD
Ospemifene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000501	0.0125	CbGpPWpGaD
Ospemifene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000501	0.0125	CbGpPWpGaD
Ospemifene—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000494	0.0123	CbGpPWpGaD
Ospemifene—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000494	0.0123	CbGpPWpGaD
Ospemifene—ESR1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000482	0.012	CbGpPWpGaD
Ospemifene—ESR1—Nuclear Receptors—VDR—multiple sclerosis	0.000478	0.0119	CbGpPWpGaD
Ospemifene—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000461	0.0115	CbGpPWpGaD
Ospemifene—ESR1—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	0.000451	0.0112	CbGpPWpGaD
Ospemifene—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000445	0.0111	CbGpPWpGaD
Ospemifene—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000445	0.0111	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000412	0.0102	CbGpPWpGaD
Ospemifene—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000406	0.0101	CbGpPWpGaD
Ospemifene—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000406	0.0101	CbGpPWpGaD
Ospemifene—ESR1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000378	0.0094	CbGpPWpGaD
Ospemifene—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000375	0.00932	CbGpPWpGaD
Ospemifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00033	0.00822	CbGpPWpGaD
Ospemifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00033	0.00822	CbGpPWpGaD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000329	0.00818	CbGpPWpGaD
Ospemifene—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000326	0.00811	CbGpPWpGaD
Ospemifene—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000326	0.00811	CbGpPWpGaD
Ospemifene—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000313	0.00779	CbGpPWpGaD
Ospemifene—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000313	0.00779	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000309	0.0077	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000309	0.00768	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000309	0.00768	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000304	0.00757	CbGpPWpGaD
Ospemifene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000296	0.00738	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	0.000285	0.00709	CbGpPWpGaD
Ospemifene—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	0.000278	0.00691	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	0.000277	0.0069	CbGpPWpGaD
Ospemifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000268	0.00666	CbGpPWpGaD
Ospemifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000268	0.00666	CbGpPWpGaD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000261	0.00649	CbGpPWpGaD
Ospemifene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000258	0.00642	CbGpPWpGaD
Ospemifene—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000257	0.0064	CbGpPWpGaD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000254	0.00631	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.000251	0.00625	CbGpPWpGaD
Ospemifene—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000237	0.00589	CbGpPWpGaD
Ospemifene—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000237	0.00589	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000233	0.00581	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000233	0.00581	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	0.000226	0.00561	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	0.000219	0.00545	CbGpPWpGaD
Ospemifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000216	0.00538	CbGpPWpGaD
Ospemifene—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000216	0.00537	CbGpPWpGaD
Ospemifene—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000216	0.00537	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000213	0.00529	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000213	0.00529	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	0.000197	0.00491	CbGpPWpGaD
Ospemifene—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000192	0.00478	CbGpPWpGaD
Ospemifene—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	0.000175	0.00436	CbGpPWpGaD
Ospemifene—ESR1—LKB1 signaling events—MYC—multiple sclerosis	0.000172	0.00428	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	0.000172	0.00427	CbGpPWpGaD
Ospemifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00017	0.00424	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	0.000168	0.00417	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000167	0.00415	CbGpPWpGaD
Ospemifene—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000164	0.00407	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000163	0.00406	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000159	0.00397	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	0.000156	0.00389	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	0.000153	0.00379	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000152	0.00378	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	0.000149	0.00371	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—ZNF746—multiple sclerosis	0.000149	0.00371	CbGpPWpGaD
Ospemifene—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000142	0.00354	CbGpPWpGaD
Ospemifene—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000142	0.00354	CbGpPWpGaD
Ospemifene—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	0.000142	0.00352	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	0.000141	0.00351	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00014	0.00349	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00014	0.00349	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—PTBP1—multiple sclerosis	0.000136	0.00339	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000134	0.00333	CbGpPWpGaD
Ospemifene—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000133	0.0033	CbGpPWpGaD
Ospemifene—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000131	0.00325	CbGpPWpGaD
Ospemifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.000125	0.00311	CbGpPWpGaD
Ospemifene—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000124	0.00307	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	0.000119	0.00297	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	0.000119	0.00296	CbGpPWpGaD
Ospemifene—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	0.000119	0.00295	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	0.000117	0.0029	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	0.000117	0.0029	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	0.000116	0.00289	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000115	0.00285	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	0.000114	0.00284	CbGpPWpGaD
Ospemifene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000113	0.0028	CbGpPWpGaD
Ospemifene—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	0.000108	0.00268	CbGpPWpGaD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	0.000104	0.00258	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	0.000103	0.00257	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—U2AF2—multiple sclerosis	0.000103	0.00257	CbGpPWpGaD
Ospemifene—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	0.0001	0.0025	CbGpPWpGaD
Ospemifene—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0001	0.00249	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	9.63e-05	0.0024	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	9.34e-05	0.00232	CbGpPWpGaD
Ospemifene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.14e-05	0.00227	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.09e-05	0.00226	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.09e-05	0.00226	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	8.76e-05	0.00218	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.28e-05	0.00206	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.28e-05	0.00206	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	8.16e-05	0.00203	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	7.74e-05	0.00193	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—SRM—multiple sclerosis	7.6e-05	0.00189	CbGpPWpGaD
Ospemifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.43e-05	0.00185	CbGpPWpGaD
Ospemifene—CYP2B6—Biological oxidations—POMC—multiple sclerosis	7.04e-05	0.00175	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	6.71e-05	0.00167	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	6.52e-05	0.00162	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—PABPC1—multiple sclerosis	6.33e-05	0.00157	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	6.3e-05	0.00157	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	6.16e-05	0.00153	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	6.13e-05	0.00152	CbGpPWpGaD
Ospemifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.03e-05	0.0015	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	5.87e-05	0.00146	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—SRM—multiple sclerosis	5.74e-05	0.00143	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—RPL5—multiple sclerosis	5.71e-05	0.00142	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—GPC5—multiple sclerosis	5.71e-05	0.00142	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.35e-05	0.00133	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.35e-05	0.00133	CbGpPWpGaD
Ospemifene—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.32e-05	0.00132	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—SRM—multiple sclerosis	5.24e-05	0.0013	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.22e-05	0.0013	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.21e-05	0.0013	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.11e-05	0.00127	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—RGS1—multiple sclerosis	4.99e-05	0.00124	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.9e-05	0.00122	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.86e-05	0.00121	CbGpPWpGaD
Ospemifene—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.85e-05	0.00121	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—GPR65—multiple sclerosis	4.73e-05	0.00118	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	4.71e-05	0.00117	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—PGR—multiple sclerosis	4.49e-05	0.00112	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCR1—multiple sclerosis	4.33e-05	0.00108	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	4.33e-05	0.00108	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.06e-05	0.00101	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.05e-05	0.00101	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.05e-05	0.00101	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.95e-05	0.000984	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.7e-05	0.000921	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.69e-05	0.000918	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.69e-05	0.000918	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.61e-05	0.000897	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—SRM—multiple sclerosis	3.45e-05	0.000859	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.37e-05	0.000839	CbGpPWpGaD
Ospemifene—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.2e-05	0.000796	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—VDR—multiple sclerosis	3.14e-05	0.000781	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCL3—multiple sclerosis	3.08e-05	0.000767	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.000763	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	2.97e-05	0.000738	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PGR—multiple sclerosis	2.92e-05	0.000727	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	2.87e-05	0.000713	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CD28—multiple sclerosis	2.84e-05	0.000706	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.8e-05	0.000696	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCR2—multiple sclerosis	2.79e-05	0.000694	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	2.59e-05	0.000645	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CNR1—multiple sclerosis	2.57e-05	0.00064	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.43e-05	0.000605	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.43e-05	0.000605	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.38e-05	0.000592	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.33e-05	0.00058	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	2.32e-05	0.000576	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.23e-05	0.000554	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.17e-05	0.00054	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.04e-05	0.000508	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CD86—multiple sclerosis	2.03e-05	0.000504	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCL5—multiple sclerosis	1.99e-05	0.000496	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.86e-05	0.000464	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.86e-05	0.000464	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—SPP1—multiple sclerosis	1.85e-05	0.000459	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.84e-05	0.000459	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCR5—multiple sclerosis	1.8e-05	0.000447	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	1.77e-05	0.00044	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.000438	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.7e-05	0.000423	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—APOE—multiple sclerosis	1.63e-05	0.000407	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.0004	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CD80—multiple sclerosis	1.48e-05	0.000368	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—POMC—multiple sclerosis	1.4e-05	0.000349	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—APOE—multiple sclerosis	1.4e-05	0.000349	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCL2—multiple sclerosis	1.37e-05	0.000342	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—MYC—multiple sclerosis	1.25e-05	0.000311	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TYK2—multiple sclerosis	1.25e-05	0.00031	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—POMC—multiple sclerosis	1.2e-05	0.0003	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000273	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—APOE—multiple sclerosis	1.06e-05	0.000264	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000263	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.04e-05	0.000258	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MMP9—multiple sclerosis	9.82e-06	0.000244	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—APOE—multiple sclerosis	9.66e-06	0.00024	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—POMC—multiple sclerosis	9.1e-06	0.000226	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—STAT3—multiple sclerosis	8.73e-06	0.000217	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—POMC—multiple sclerosis	8.3e-06	0.000206	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—ALB—multiple sclerosis	8.3e-06	0.000206	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MYC—multiple sclerosis	8.12e-06	0.000202	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	8.1e-06	0.000201	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	7.94e-06	0.000198	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—ALB—multiple sclerosis	7.57e-06	0.000188	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—APOE—multiple sclerosis	6.37e-06	0.000159	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IL6—multiple sclerosis	6.1e-06	0.000152	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—POMC—multiple sclerosis	5.47e-06	0.000136	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—ALB—multiple sclerosis	4.99e-06	0.000124	CbGpPWpGaD
